Results 11 to 20 of about 6,841 (195)
Tamsulosin and risk of priapism: A causality assessment using Austin Bradford Hill Criteria [PDF]
Pharmacology Research & Perspectives, 2022 Tamsulosin hydrochloride, a selective alpha‐adrenergic blocking agent has been previously associated with priapism. Priapism is a medically serious condition that, if not intervened, can cause permanent erectile dysfunction.
Mulugeta Russom +4 more
doaj +2 more sources
Jurnal Urologi Indonesia, 2020 Objective: To assess the difference in the administration of 0.2 mg and 0.4 mg tamsulosin to the patient's complaint with DJ stent based on USSQ parameters. Material & Methods: This was a prospective study conducted in Hasan Sadikin Hospital Bandung from
Dhika Ari Rizki +2 more
doaj +3 more sources
The relaxant effect of Tamsulosin in the vascular reactivity of goat isolated renal artery
Kurdistan Journal of Applied Research, 2019 Alpha-blockers including tamsulosin, are medications that relax muscles in the urinary tract to facilitate stone passage into the bladder. This research aimed to investigate the possible action of tamsulosin (1 × 10-3 – 10-8 M), in the vascular ...
Aveen Muhsin Asaad +1 more
doaj +5 more sources
International Journal of General Medicine, 2011 Sakineh Hajebrahimi1, Yadollah Ahmadi Asrbadr1, Arash Azaripour1, Homayoun Sadeghi-Bazargani2,31Urology Department, Imam Reza University Hospital, Tabriz, Iran; 2Neuroscience Research Center and RDCC, Tabriz University of Medical Sciences, Tabriz, Iran ...
Sakineh Hajebrahimi +3 more
doaj +2 more sources
Effect of tamsulosin on testis histopathology and serum hormones in adult rats: Experimental study
International Journal of Reproductive BioMedicine, 2020 Background: Tamsulosin is an inhibitory factor of alpha-adrenergic receptors that is used for relieving of the clinical symptoms and management of acute urinary retention.
Yegane Kohestani +3 more
doaj +2 more sources
World Journal of Urology, 2002 This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent.
Christopher, Chapple +1 more
core +4 more sources
Current Medical Research and Opinion, 2015 To evaluate the efficacy and safety of tamsulosin and solifenacin combination therapy compared with tamsulosin monotherapy for male lower urinary tract symptoms (LUTS).
Shaopeng Qiu, Runqiang Yuan
exaly +2 more sources
EFIKASI TAMSULOSIN PADA BENIGN PROSTATIC HYPERPLASIA DENGAN RETENSIO URINE AKUT YANG MENJALANI TRIAL WITHOUT CATHETER [PDF]
Jurnal Urologi Indonesia, 2016 Objective: To evaluate the efficacy of tamsulosin on BPH patients with acute urinary retention on trial without catheter (TWOC). Materials & method: This study was a post test only-placebo group design comparing residual urine in BPH patients with acute ...
Khoirul Kholis +3 more
doaj +4 more sources
Comparative efficacy of tamsulosin versus nifedipine for distal ureteral calculi: a meta-analysis
Drug Design, Development and Therapy, 2016 Hai Wang, Li Bo Man, Guang Lin Huang, Gui Zhong Li, Jian Wei WangDepartment of Urology, Beijing Jishuitan Hospital, Beijing, People’s Republic of China Objective: The aim of this study was to systematically compare the therapeutic effect and safety
Wang H, Man LB, Huang GL, Li GZ, Wang JW
doaj +1 more source
An infrequent but unpleasant adverse event of Tamsulosin [PDF]
Advances in Medicine, Psychology, and Public HealthTamsulosin, a selective α1-adrenoceptor antagonist, is primarily approved for managing benign prostatic hyperplasia. Its off-label application in facilitating the spontaneous passage of ureteral stones, particularly in cases of renal colic, has gained ...
Antonio Villa
doaj +2 more sources